Market Overview:
The global Hysteroscopy Instruments Marketwas valued at USD 1.06 billion in 2016 and is projected to reach USD 1.95 billion by 2025, growing at a CAGR of 6.98% from 2017 to 2025.
The market of these instruments is seeing a hike due to advantages provided by the technology and reduced chances of invasion in patient’s body. The risk of procedural exposure to microorganisms is minimal. Healthcare and medical sector prefer the Hysteroscopy Instruments over traditional techniques.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Increasing cases of gynecological diseases in the female population
1.2 Increasing demand of invasive treatments
1.3 Growing adoption of Hysteroscopy
1.4 Technological advancements
2. Market Restraints
2.1 Side effects of the technique
2.2 Availability of Alternatives
Market Segmentation:
1. Global Hysteroscopy Instruments Market, by Application:
1.1 Diagnostic Hysteroscopy
1.2 Operative Hysteroscopy
1.3 Myomectomy
1.4 Polypectomy
1.5 Endometrial Ablation
1.6 Tubal Sterilization
2. Global Hysteroscopy Instruments Market, by End User:
2.1 Hospitals
2.2 Ambulatory Surgery Centers
2.3 Other End Users
3. Global Hysteroscopy Instruments Market, by Usability:
3.1 Reusable Instruments
3.2 Disposable Instruments
4. Global Hysteroscopy Instruments Market, by Type:
4.1 Hysteroscopes
4.1.1 Rigid Hysteroscopes
4.1.2 Flexible Hysteroscopes
4.2 Resectoscopes
4.2.1 Bipolar Resectoscopes
4.2.2 Unipolar Resectoscopes
4.3 Fluid Management Systems
4.4 Handheld Instruments
4.4.1 Forceps
4.4.2 Scissors
4.4.3 Dilators
4.4.4 Other Tissue Removal Systems
4.5 Hysterosheaths
4.6 Hysteroscopic Tissue Removal Systems
5. Global Hysteroscopy Instruments Market, by Region:
5.1 North America (U.S., Canada, Mexico)
5.2 Europe (Germany, UK, France, Rest of Europe)
5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
5.4 Latin America (Brazil, Argentina, Rest of Latin America)
5.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Medtronic PLC.
2. Ethicon, Inc. (A Subsidiary of Johnson & Johnson)
3. B. Braun Melsungen AG
4. Olympus Corporation
5. Karl Storz GmbH & Co. Kg
6. Stryker Corporation
7. Hologic, Inc.
8. Boston Scientific Corporation
9. Medgyn Products, Inc.
10. Richard Wolf GmbH
11. Coopersurgical, Inc. (A Unit of the Cooper Companies, Inc.)
12. Cook Medical
13. MaxerMedizintechnik GmbH
14. Medicon EG
15. HospilineEquipments Pvt. Ltd.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Hysteroscopy Instruments Marketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL HYSTEROSCOPY INSTRUMENTS MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL HYSTEROSCOPY INSTRUMENTS MARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 Global Hysteroscopy Instruments Market, by Application:
5.1 Diagnostic Hysteroscopy
5.2 Operative Hysteroscopy
5.3 Myomectomy
5.4 Polypectomy
5.5 Endometrial Ablation
5.6 Tubal Sterilization
6 Global Hysteroscopy Instruments Market, by End User:
6.1 Hospitals
6.2 Ambulatory Surgery Centers
6.3 Other End Users
7 Global Hysteroscopy Instruments Market, by Usability:
7.1 Reusable Instruments
7.2 Disposable Instruments
8 Global Hysteroscopy Instruments Market, by Type:
8.1 Hysteroscopes
8.1.1 Rigid Hysteroscopes
8.1.2 Flexible Hysteroscopes
8.2 Resectoscopes
8.2.1 Bipolar Resectoscopes
8.2.2 Unipolar Resectoscopes
8.3 Fluid Management Systems
8.4 Handheld Instruments
8.4.1 Forceps
8.4.2 Scissors
8.4.3 Dilators
8.4.4 Other Tissue Removal Systems
8.5 Hysterosheaths
8.6 Hysteroscopic Tissue Removal Systems
9 GLOBAL HYSTEROSCOPY INSTRUMENTS MARKET, BY GEOGRAPHY
9.1 Overview
9.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 â€" 2025
10 GLOBAL HYSTEROSCOPY INSTRUMENTS MARKETCOMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies
11 COMPANY PROFILES
11.1 Medtronic PLC.
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments
11.2 Ethicon, Inc.
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments
11.3 B. Braun Melsungen AG
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments
11.4 Olympus Corporation
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments
11.5 Karl Storz GmbH & Co. Kg
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments
11.6 Stryker Corporation
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments
11.7 Hologic, Inc.
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments
11.8 Boston Scientific Corporation
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments
11.9 Medgyn Products, Inc.
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Developments
11.10 Richard Wolf GmbH
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Developments
11.11 Cooper Surgical, Inc.
11.11.1 Overview
11.11.2 Financial Performance
11.11.3 Product Outlook
11.11.4 Key Developments
11.12 Cook Medical
11.12.1 Overview
11.12.2 Financial Performance
11.12.3 Product Outlook
11.12.4 Key Developments
11.13 Maxer Medizintechnik GmbH
11.13.1 Overview
11.13.2 Financial Performance
11.13.3 Product Outlook
11.13.4 Key Developments
11.14 Medicon EG
11.14.1 Overview
11.14.2 Financial Performance
11.14.3 Product Outlook
11.14.4 Key Developments
11.15 Hospiline Equipments Pvt. Ltd.
11.15.1 Overview
11.15.2 Financial Performance
11.15.3 Product Outlook
11.15.4 Key Developments
12 Appendix
12.1 Related Reports
Asia Pacific bioprocess technology market will grow by 15.0% annually with a total addressable market cap of $170.71 billion over 2024-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology...
Europe bioprocess technology market was valued at $6.56 billion in 2023 and will grow by 13.7% annually over 2023-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology sector, ongoing tech...
North America bioprocess technology market is projected to grow by 13.3% annually in the forecast period and reach $29.68 billion by 2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology s...
Global bioprocess technology market will reach $88.39 billion by 2033, growing by 13.8% annually over 2023-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology sector, ongoing technologic...
Asia Pacific neurosurgical robotics market will grow by 20.6% annually with a total addressable market cap of $6.61 billion over 2023-2032, driven by the rising number of robot-based and computer-assisted neurosurgical procedures, the advantages of neurosurgical robots, technological innovation and ...
Europe neurosurgical robotics market was valued at $332.8 million in 2022 and will grow by 16.9% annually over 2022-2032, driven by the rising number of robot-based and computer-assisted neurosurgical procedures, the advantages of neurosurgical robots, technological innovation and growing R&D invest...
North America neurosurgical robotics market is projected to grow by 16.4% annually in the forecast period and reach $3.53 billion by 2032, driven by the rising number of robot-based and computer-assisted neurosurgical procedures, the advantages of neurosurgical robots, technological innovation and g...
Global neurosurgical robotics market will reach $6.7 billion by 2032, growing by 17.2% annually over 2022-2032, driven by the rising number of robot-based and computer-assisted neurosurgical procedures, the advantages of neurosurgical robots, technological innovation and growing R&D investment, and ...
The global High Content Screening(HCS) Instruments market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help mar...
The global Bioprocess Instruments market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in th...